Canton Strategic Holdings, Inc. (CNTN)
2.24
+0.16
(+7.69%)
USD |
NASDAQ |
Sep 03, 16:00
2.24
0.00 (0.00%)
After-Hours: 20:00
Canton Strategic Holdings Enterprise Value : 123.49M for Sept. 2, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| September 02, 2026 | 123.49M |
| September 01, 2026 | 138.94M |
| August 31, 2026 | 138.94M |
| August 28, 2026 | 134.30M |
| August 27, 2026 | 144.35M |
| August 26, 2026 | 135.08M |
| August 25, 2026 | 141.26M |
| August 24, 2026 | 128.12M |
| August 21, 2026 | 131.99M |
| August 20, 2026 | 133.53M |
| August 19, 2026 | 124.26M |
| August 18, 2026 | 118.08M |
| August 17, 2026 | 119.24M |
| August 14, 2026 | 118.85M |
| August 13, 2026 | 114.99M |
| August 12, 2026 | 114.99M |
| August 11, 2026 | 109.58M |
| August 10, 2026 | 107.26M |
| August 07, 2026 | 107.26M |
| August 06, 2026 | 106.49M |
| August 05, 2026 | 109.58M |
| August 04, 2026 | 110.35M |
| August 03, 2026 | 117.30M |
| July 31, 2026 | 111.90M |
| July 30, 2026 | 105.71M |
| Date | Value |
|---|---|
| July 29, 2026 | 111.90M |
| July 28, 2026 | 120.40M |
| July 27, 2026 | 119.62M |
| July 24, 2026 | 112.67M |
| July 23, 2026 | 121.94M |
| July 22, 2026 | 124.26M |
| July 21, 2026 | 129.67M |
| July 20, 2026 | 121.17M |
| July 17, 2026 | 140.49M |
| July 16, 2026 | 143.58M |
| July 15, 2026 | 147.44M |
| July 14, 2026 | 140.49M |
| July 13, 2026 | 138.17M |
| July 10, 2026 | 146.67M |
| July 09, 2026 | 139.71M |
| July 08, 2026 | 142.03M |
| July 07, 2026 | 155.94M |
| July 06, 2026 | 160.96M |
| July 02, 2026 | 182.21M |
| July 01, 2026 | 189.94M |
| June 30, 2026 | 180.67M |
| June 29, 2026 | 115.97M |
| June 26, 2026 | 126.74M |
| June 25, 2026 | 110.59M |
| June 24, 2026 | 109.46M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 11.82B |
| Oncolytics Biotech, Inc. | 106.01M |
| Sangamo Therapeutics, Inc. | 62.59M |
| Sarepta Therapeutics, Inc. | 2.709B |
| Anixa Biosciences, Inc. | 91.43M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -17.95M |
| Revenue (Quarterly) | 1.496M |
| Total Expenses (Quarterly) | 19.45M |
| EPS Diluted (Quarterly) | -0.0888 |
| Profit Margin (Quarterly) | -1.20K% |
| Earnings Yield | -64.56% |
| Normalized Earnings Yield | -40.35 |